Basics Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $1.36B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.57% Avg Daily Range (30 D): $0.56 | 3.12% Avg Daily Range (90 D): $0.58 | 3.08% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): 1.45M Avg Daily Volume (90 D): 1.45M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 3,092 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $2.44M Avg Inst. Trade (90 D): $2.56M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.83M Avg Closing Trade (30 D): $4.14M Avg Closing Trade (90 D): $4.91M Avg Closing Volume: 168.12K         News Mar 17, 2025 @ 11:01 AM Travere Therapeutics Submits sNDA to FDA for Appro... Source: N/A Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Nov 13, 2024 @ 10:00 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Nov 8, 2024 @ 2:05 AM Travere Therapeutics Announces Pricing of Public O... Source: Globe Newswire Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.47 $-.7 Diluted EPS $-.47 $-.7 Revenue $ $ 81.73M $ 62.9M Gross Profit $ $ 77.05M $ 61.27M Net Income / Loss $ $ -41.23M $ -54.81M Operating Income / Loss $ $ -42.67M $ -56.15M Cost of Revenue $ $ 4.68M $ 1.63M Net Cash Flow $ $ 3.36M $ 4.12M PE Ratio     Splits Nov 08, 2011:   1:9